Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Jeske

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implicationNasiredin Sadeghi, Daniel Kahn, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 8, 2012
Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparinAngel Gray, Evangelos Litinas, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2012
A comparison of the pharmacodynamic behavior of branded and biosimilar enoxaparin in primatesWalter Jeske, Evangelos Litinas, Hussein Khan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 4, 2019
Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine HeparinsAhmed Kouta, Walter Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 8, 2020
Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its ComponentsFakiha Siddiqui, Debra Hoppensteadt, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 10, 2022
Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet AlfaJoseph Lewis, Omer Iqbal, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 16, 2019
Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic SpectrumFakiha Siddiqui, Debra Hoppensteadt, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 24, 2024
Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine SulfateFakiha Siddiqui, Debra Hoppensteadt, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 9, 2003
Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory testsMahmut Tobu, Omer Iqbal, Debra A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2009
Comparative studies on the topical administration of mucopolysaccharide and heparin ointments in nonhuman primatesDebra A Hoppensteadt, Brian Neville, Christopher Schultz, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implicationNasiredin Sadeghi, Daniel Kahn, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 8, 2012
Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparinAngel Gray, Evangelos Litinas, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2012
A comparison of the pharmacodynamic behavior of branded and biosimilar enoxaparin in primatesWalter Jeske, Evangelos Litinas, Hussein Khan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 4, 2019
Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine HeparinsAhmed Kouta, Walter Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 8, 2020
Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its ComponentsFakiha Siddiqui, Debra Hoppensteadt, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 10, 2022
Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet AlfaJoseph Lewis, Omer Iqbal, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 16, 2019
Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic SpectrumFakiha Siddiqui, Debra Hoppensteadt, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 24, 2024
Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine SulfateFakiha Siddiqui, Debra Hoppensteadt, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 9, 2003
Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory testsMahmut Tobu, Omer Iqbal, Debra A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2009
Comparative studies on the topical administration of mucopolysaccharide and heparin ointments in nonhuman primatesDebra A Hoppensteadt, Brian Neville, Christopher Schultz, et al.
Pageof 7